Therapeutic Focus

Ception Therapeutics is focused on the discovery and development of novel products to address areas of unmet medical need. The Company's pipeline includes reslizumab in clinical development for eosinophilic inflammatory conditions and an orally available small molecule anti-TNF program. Ception Therapeutics pursues new drug targets through a proprietary thermodynamics-based rational drug design program.